# Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice

> **NCT01759251** · — · COMPLETED · sponsor: **Abbott** · enrollment: 309 (actual)

## Conditions studied

- Vertigo

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01759251
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2015-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01759251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01759251, "Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01759251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*